(Q46501916)

English

A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer.

scientific article published in May 2005

Statements

A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit